These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 7386381)
1. Improving international drug cooperation. Voss EH Am Pharm; 1980 Apr; NS20(4):8-9. PubMed ID: 7386381 [No Abstract] [Full Text] [Related]
2. [Problems of an international nature in the registration of drugs for veterinary use]. Lorenzini RN Ann Ist Super Sanita; 1984; 20(4):271-4. PubMed ID: 6546274 [No Abstract] [Full Text] [Related]
3. Quality control of drugs: certification scheme on the quality of pharmaceutical products moving in international commerce. WHO Chron; 1980 Nov; 34(11):427-32. PubMed ID: 7467274 [No Abstract] [Full Text] [Related]
4. WHO expert committee on drug dependence. World Health Organ Tech Rep Ser; 1995; 856():1-17. PubMed ID: 8928523 [No Abstract] [Full Text] [Related]
5. [International cooperation in assembling adverse drug effects. A scientific trial program as a pilot study of the World Health Organization]. Homann G Zahnarztl Mitt; 1968 Jul; 58(13):635-6. PubMed ID: 5243097 [No Abstract] [Full Text] [Related]
6. WHO launches taskforce to fight counterfeit drugs. Burns W Bull World Health Organ; 2006 Sep; 84(9):689-90. PubMed ID: 17128332 [No Abstract] [Full Text] [Related]
7. FDA's consideration of Codex Alimentarius standards in light of international trade agreements. Sikes L Food Drug Law J; 1998; 53(2):327-35. PubMed ID: 10346688 [No Abstract] [Full Text] [Related]
8. Resisting political impulses. Sonnenreich MR; Kline NS J Leg Med (N Y); 1974; 2(3):48-52. PubMed ID: 4546227 [No Abstract] [Full Text] [Related]
9. The convention on psychotropic substances: why it should be ratified. Rosen JA J Leg Med (N Y); 1974; 2(3):44-7. PubMed ID: 4546226 [No Abstract] [Full Text] [Related]
10. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
11. Panel discussion: problems arising from differences in domestic and international regulations. Bull Parenter Drug Assoc; 1973; 27(3):126-38. PubMed ID: 4709160 [No Abstract] [Full Text] [Related]
12. Remarks at the Food and Drug Law Institute's 48th Annual Conference. Niedelman SM Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089 [No Abstract] [Full Text] [Related]
13. 2008 World Drug Report: a more pragmatic approach needed to combat illicit drug use. Vashishtha VM Indian Pediatr; 2008 Sep; 45(9):767-8. PubMed ID: 18820384 [No Abstract] [Full Text] [Related]
14. [Drug problems and the Common Market. Personal views]. Andersen AH Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706 [No Abstract] [Full Text] [Related]
15. Canadian drugs: panacea or problem? State Legis; 2004 Jun; 30(6):9. PubMed ID: 15179953 [No Abstract] [Full Text] [Related]
17. Knockoffs on the pharmacy shelf. Pasternak D US News World Rep; 2001 Jun; 130(23):26-7. PubMed ID: 11419218 [No Abstract] [Full Text] [Related]
18. What role can public health institutions play in drug development for the poor? A case study of artesunate. Gomes M; Olliaro P; Folb P Med Trop (Mars); 1998; 58(3 Suppl):97-100. PubMed ID: 10212912 [TBL] [Abstract][Full Text] [Related]
19. Post-marketing surveillance and adverse drug reactions. Shani S Isr Med Assoc J; 1999 Oct; 1(2):117-9. PubMed ID: 10731310 [No Abstract] [Full Text] [Related]
20. [International regulations of narcotics--role of WHO]. Yanagida T Seishin Shinkeigaku Zasshi; 1987; 89(12):1023-8. PubMed ID: 3452841 [No Abstract] [Full Text] [Related] [Next] [New Search]